Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. is focused on developing and commercializing products for the treatment of central nervous system disorders, including: ADHD, mood disorders, epilepsy, migraine, and Parkinson’s disease. 
Our 30-year history in product development is exemplified by the success of more than 10 widely recognized products.